In short
This article discusses the use of "Other Emollients and Protectives" in clinical trials for treating atopic dermatitis. These trials aim to evaluate the safety and effectiveness of new treatments for moderate to severe atopic dermatitis in adults. The focus is on understanding how these emollients and protectives may help manage symptoms and improve the quality of life for patients with this chronic skin condition.
At a glance
- Study Type
- Phase 2, Randomized, Double-Blind, Placebo-Controlled
- Duration
- 52 weeks
- Condition
- Moderate-to-Severe Atopic Dermatitis
- Main Objective
- Compare efficacy of LY3454738 vs placebo using EASI-75
- Key Inclusion Criteria
- Active atopic dermatitis for over a year, EASI score ≥ 12, vIGA-AD score ≥3, ≥10% BSA involvement
- Key Exclusion Criteria
- Prior skin infections requiring topical corticosteroids, history of psoriasis, certain infections
- Treatment Category
- Other Emollients and Protectives
- Administration Route
- Topical
What are OTHER EMOLLIENTS AND PROTECTIVES?
OTHER EMOLLIENTS AND PROTECTIVES refer to a group of topical treatments used to moisturize and protect the skin. These products are designed to help manage various skin conditions, particularly those characterized by dryness, itching, and inflammation. In the context of this article, we'll be focusing on their potential use in treating atopic dermatitis, also known as eczema.
Atopic Dermatitis: The Target Condition
Atopic dermatitis is a chronic skin condition characterized by dry, itchy, and inflamed skin. It's a type of eczema that can significantly impact a person's quality of life. The condition often requires ongoing management and treatment to control symptoms and prevent flare-ups.
Clinical Trial Information
A clinical trial is currently being conducted to evaluate a new treatment for moderate-to-severe atopic dermatitis in adults. While the main focus of the trial is on a drug called LY3454738, it's important to note that OTHER EMOLLIENTS AND PROTECTIVES are also being studied as part of the treatment regimen.
The trial aims to compare the effectiveness of the new treatment against a placebo. The main goal is to see if the treatment can significantly improve the symptoms of atopic dermatitis, as measured by a scale called the Eczema Area and Severity Index (EASI). Specifically, they're looking at how many participants can achieve a 75% improvement in their EASI score, which is referred to as EASI-75.
Eligibility Criteria for the Study
To participate in this study, patients need to meet certain criteria. These include:
- Having active atopic dermatitis for over a year
- Having a certain level of severity as measured by specific scales:
- An EASI score of 12 or higher
- A vIGA-AD score (another measure of severity) of 3 or higher
- At least 10% of body surface area affected by atopic dermatitis
- Having little improvement with topical medicines in the past
There are also conditions that would exclude someone from participating, such as:
- Recent skin infections requiring treatment with topical corticosteroids
- A history of psoriasis (another skin condition)
- Certain other infections like Hepatitis B or C
- Known allergies to the study drug or its components
Treatment Details
The OTHER EMOLLIENTS AND PROTECTIVES used in this study are applied topically, meaning they are put directly on the skin. They are classified as "chemical" products, which means they are synthetically produced rather than derived from natural sources.
The exact dosage and frequency of application are not specified in the provided information. However, it's noted that the maximum treatment period is set at 1 week. This could mean that the emollients and protectives are used as part of a short-term treatment plan, possibly in conjunction with other medications being studied.
Potential Benefits and Considerations
Emollients and protectives are generally used to moisturize and protect the skin, which can be particularly beneficial for people with atopic dermatitis. They may help to:
- Reduce skin dryness
- Alleviate itching
- Improve the skin's barrier function
- Potentially reduce the need for other medications like topical corticosteroids
However, it's important to note that this is an investigational treatment. The full effects and potential side effects are still being studied. As with any medical treatment, it's crucial to discuss the potential benefits and risks with a healthcare provider.